Standout Papers

High-fidelity CRISPR–Cas9 nucleases with no detectable genome-wide off-target effects 2015 2026 2018 2022 1.9k
  1. High-fidelity CRISPR–Cas9 nucleases with no detectable genome-wide off-target effects (2016)
    Benjamin P. Kleinstiver, Vikram Pattanayak et al. Nature
  2. Engineered CRISPR-Cas9 nucleases with altered PAM specificities (2015)
    Benjamin P. Kleinstiver, Michelle S. Prew et al. Nature
  3. Genome-wide specificities of CRISPR-Cas Cpf1 nucleases in human cells (2016)
    Benjamin P. Kleinstiver, Shengdar Q. Tsai et al. Nature Biotechnology
  4. Broadening the targeting range of Staphylococcus aureus CRISPR-Cas9 by modifying PAM recognition (2015)
    Benjamin P. Kleinstiver, Michelle S. Prew et al. Nature Biotechnology

Immediate Impact

48 by Nobel laureates 57 from Science/Nature 169 standout
Sub-graph 1 of 11

Citing Papers

Past, present, and future of CRISPR genome editing technologies
2024 Standout
A Vacancy‐Engineering Ferroelectric Nanomedicine for Cuproptosis/Apoptosis Co‐Activated Immunotherapy
2024 Standout
101 intermediate papers

Works of Michelle S. Prew being referenced

The conformational stability of pro-apoptotic BAX is dictated by discrete residues of the protein core
2021
High-fidelity CRISPR–Cas9 nucleases with no detectable genome-wide off-target effects
2016 StandoutNature
and 4 more

Author Peers

Author Last Decade Papers Cites
Michelle S. Prew 4193 241 5 907 571 14 4.3k
Ved V. Topkar 4049 228 4 878 536 15 4.2k
Vikram Pattanayak 4062 232 3 961 529 22 4.3k
Eli J. Fine 4502 274 12 1067 453 19 4.9k
Gang Bao 4036 216 6 876 400 11 4.4k
Alexander A. Sousa 4879 267 9 1329 549 13 5.1k
Nicole M. Gaudelli 4069 232 17 1169 386 18 4.3k
Evan H. Whitehead 5360 303 6 1032 344 19 6.0k
John A. Zuris 5634 323 40 1382 524 23 6.2k
Linyi Gao 3407 161 5 674 383 22 3.9k
Cyd Khayter 5938 306 4 1378 702 11 6.4k

All Works

Loading papers...

Rankless by CCL
2026